Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tyde Wellness vs Vea Health

Tyde Wellness
Graded #39

Higher grade

vs+24.799999999999997
Vea Health
Graded #450

Lower grade

The verdict

Tyde Wellness takes it — 79.8/100 to 55/100.

Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde Wellness is a 50-state compounded-GLP-1 and longevity telehealth platform spanning weight loss, HRT, hair, and peptides.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTyde Wellness +41
86
45
Dose & formulationTyde Wellness +32
83
51
Clinical oversightTyde Wellness +23
89
66
Labs & monitoringTyde Wellness +2
54
52
FulfillmentTyde Wellness +23
91
68
Contract termsTyde Wellness +6
61
55
Tyde Wellness · left barVea Health · right bar

The numbers

MetricTyde WellnessVea Health
WeighScore79.8/10055/100
GradeC+C
Scorecard rank#39#450
Semaglutide$149/mo (microdose tier, all doses, compounded)Not disclosed
Tirzepatide$249/mo (microdose tier, all doses, compounded)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Tyde Wellness

Graded #39 · C+

Strengths

  • All 50 states served (full list published)
  • Transparent pricing: semaglutide from $149/mo, tirzepatide from $249/mo
  • LegitScript Certified with a verification link
  • Five named 503A pharmacy partners with addresses: Belmar (CO), Casa (TX), Olympia (FL), Red Rock (UT), Beaker (TX)
  • Free consultation; cancel-anytime subscription with no long-term commitment

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic)
  • Tirzepatide priced higher than competitors offering $200-$249/mo
  • Corporate address and medical director not publicly disclosed
  • No NABP .pharmacy seal visible
Vea Health

Graded #450 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard